JPH04504256A - ペプチド、免疫原性のある組成物、それを含むワクチンまたは製剤、哺乳動物にlhrhに対する免疫性を付与する方法および豚の肉質を向上させる方法 - Google Patents
ペプチド、免疫原性のある組成物、それを含むワクチンまたは製剤、哺乳動物にlhrhに対する免疫性を付与する方法および豚の肉質を向上させる方法Info
- Publication number
- JPH04504256A JPH04504256A JP2505371A JP50537190A JPH04504256A JP H04504256 A JPH04504256 A JP H04504256A JP 2505371 A JP2505371 A JP 2505371A JP 50537190 A JP50537190 A JP 50537190A JP H04504256 A JPH04504256 A JP H04504256A
- Authority
- JP
- Japan
- Prior art keywords
- lhrh
- peptide
- peptides
- trp
- amino acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 44
- XLXSAKCOAKORKW-UHFFFAOYSA-N gonadorelin Chemical compound C1CCC(C(=O)NCC(N)=O)N1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 XLXSAKCOAKORKW-UHFFFAOYSA-N 0.000 title claims abstract description 43
- 101000904173 Homo sapiens Progonadoliberin-1 Proteins 0.000 title claims abstract description 37
- 102100024028 Progonadoliberin-1 Human genes 0.000 title claims abstract description 37
- 101000996723 Sus scrofa Gonadotropin-releasing hormone receptor Proteins 0.000 title claims abstract description 37
- 241000282887 Suidae Species 0.000 title claims abstract description 33
- 241000124008 Mammalia Species 0.000 title claims abstract description 9
- 229960005486 vaccine Drugs 0.000 title claims description 27
- 102000004196 processed proteins & peptides Human genes 0.000 title claims description 18
- 239000000203 mixture Substances 0.000 title claims description 17
- 230000002163 immunogen Effects 0.000 title claims description 14
- 238000000034 method Methods 0.000 title claims description 12
- 235000013372 meat Nutrition 0.000 title claims description 10
- 230000036039 immunity Effects 0.000 title claims description 8
- 238000009472 formulation Methods 0.000 title description 4
- 238000002255 vaccination Methods 0.000 claims abstract description 13
- 150000001413 amino acids Chemical class 0.000 claims description 31
- 238000002360 preparation method Methods 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 6
- LKKMLIBUAXYLOY-UHFFFAOYSA-N 3-Amino-1-methyl-5H-pyrido[4,3-b]indole Chemical compound N1C2=CC=CC=C2C2=C1C=C(N)N=C2C LKKMLIBUAXYLOY-UHFFFAOYSA-N 0.000 claims description 5
- 101150079396 trpC2 gene Proteins 0.000 claims description 5
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 claims description 4
- 125000006850 spacer group Chemical group 0.000 claims description 4
- 239000013589 supplement Substances 0.000 claims description 4
- ODHCTXKNWHHXJC-GSVOUGTGSA-N Pyroglutamic acid Natural products OC(=O)[C@H]1CCC(=O)N1 ODHCTXKNWHHXJC-GSVOUGTGSA-N 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 claims description 3
- BEBCJVAWIBVWNZ-UHFFFAOYSA-N glycinamide Chemical group NCC(N)=O BEBCJVAWIBVWNZ-UHFFFAOYSA-N 0.000 claims description 3
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims description 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 6
- 239000004615 ingredient Substances 0.000 claims 1
- 239000005556 hormone Substances 0.000 abstract description 7
- 229940088597 hormone Drugs 0.000 abstract description 7
- 235000001014 amino acid Nutrition 0.000 description 24
- 241001465754 Metazoa Species 0.000 description 19
- 102000014914 Carrier Proteins Human genes 0.000 description 7
- 108010078791 Carrier Proteins Proteins 0.000 description 7
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000003814 drug Substances 0.000 description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 4
- 238000003307 slaughter Methods 0.000 description 4
- 239000003098 androgen Substances 0.000 description 3
- 229940030486 androgens Drugs 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 3
- 235000018417 cysteine Nutrition 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 150000003431 steroids Chemical class 0.000 description 3
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 206010062767 Hypophysitis Diseases 0.000 description 2
- 206010060862 Prostate cancer Diseases 0.000 description 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 210000004899 c-terminal region Anatomy 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Natural products OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000000539 dimer Substances 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 238000009806 oophorectomy Methods 0.000 description 2
- 210000003635 pituitary gland Anatomy 0.000 description 2
- 239000000583 progesterone congener Substances 0.000 description 2
- 210000001625 seminal vesicle Anatomy 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229960003604 testosterone Drugs 0.000 description 2
- 210000003708 urethra Anatomy 0.000 description 2
- 201000010653 vesiculitis Diseases 0.000 description 2
- ONNFVCVQECBCIU-MERQFXBCSA-N (2s)-2-formamido-3-(1h-indol-3-yl)propanoic acid;1h-indole Chemical compound C1=CC=C2NC=CC2=C1.C1=CC=C2C(C[C@@H](C(=O)O)NC=O)=CNC2=C1 ONNFVCVQECBCIU-MERQFXBCSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 108700012941 GNRH1 Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 239000000579 Gonadotropin-Releasing Hormone Substances 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 208000037824 growth disorder Diseases 0.000 description 1
- 231100000001 growth retardation Toxicity 0.000 description 1
- 108060003552 hemocyanin Proteins 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000000938 luteal effect Effects 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 238000009304 pastoral farming Methods 0.000 description 1
- -1 peptide) Chemical class 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 229940095055 progestogen systemic hormonal contraceptives Drugs 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000011869 shoot development Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 210000004885 white matter Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Reproductive Health (AREA)
- Virology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Description
Claims (11)
- 1.タンデム中で2個以上のLHRHから成ることを特徴とするペプチド。
- 2.次の一般式(左側にアミノ末端アミノ酸があり、右側にカルボキシ末端アミ ノ酸がある)で表示されるタンデム中に2個以上のLHRH系列を有することを 特徴とするペプチド: 【配列があります】 ここでアミノ酸は三文字コードで選定され、Trp1とTrp2はTrpかある いはN−ホルミル−Trpのどちらかであり、nは1以上の値を有する番号であ り、Xは直接結合かあるいはアミノ酸のGIyかGlnの間にあるスペーサー基 のどちらかであり、Z1−Glxは1個以上の付加アミノ酸から成る尾に結合し たpGlu(ピログルタミン酸)かあるいはGlnのどちらかであり、そしてG ly−Z2は1個以上の付加アミノ酸から成る尾に結合したGly−NH2かあ るいはGlyのどちらかである。
- 3.次の一般式(左側にアミノ末端アミノ酸があり、右側にカルボキシ末端アミ ノ酸がある)で表示されるタンデム中に2個以上のLHRH系列を含有すること を特徴とするペプチド: 【配列があります】 ここでアミノ酸は三文字コードで選定され、Trp1とTrp2はTrpかある いはN−ホルミル−Trpのいずれかであり、そしてnは1以上の値を有する番 号である。
- 4.次式(左側にアミノ末端アミノ酸があり、右側にカルボキシ末端アミノ酸が ある)で表示されるタンデム中に2個のLHRH系列を含有することを特徴とす るペプチド: 【配列があります】 ここでアミノ酸は三文字コードで選定され、そしてTrp1とTrp2はTrp かあるいはN−ホルミル−Trpのいずれかである。
- 5.免疫原性のある形態にした特許請求の範囲1〜4のいずれかによるペプチド から成ることを特徴とする組成物。
- 6.特許請求の範囲1〜4のいずれかによる蛋白質とペプチドの免疫原性のある 配合体から成ることを特徴とする組成物。
- 7.特許請求の範囲1〜4のいずれかによるペプチドが所属する免疫原性のある 複合体から成ることを特徴とする組成物。
- 8.特許請求の範囲1〜4のいずれかによるペプチドが所属する免疫原性のある 遺伝子組替え蛋白質から成ることを特徴とする組成物。
- 9.1個以上の免疫補佐剤と結合する特許請求の範囲5〜8のいずれかによる組 成物から成ることを特徴とするワクチンまたは治癒力のある製剤。
- 10.哺乳動物に特許請求の範囲9によるワクチン製剤によるワクチン接種を行 うことを特徴とする該哺乳動物にLHRHに対する免疫性を付与する方法。
- 11.豚に特許請求の範囲9によるワクチン製剤によるワクチン接種を行うこと を特徴とする該豚の肉質を向上させる方法。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL8900726 | 1989-03-23 | ||
NL8900726A NL8900726A (nl) | 1989-03-23 | 1989-03-23 | Peptide, immunogene samenstelling en vaccin- of geneesmiddelpreparaat; werkwijze voor het immuniseren van een zoogdier tegen lhrh, en werkwijze voor het verbeteren van de vleeskwaliteit van varkens. |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH04504256A true JPH04504256A (ja) | 1992-07-30 |
JP3098771B2 JP3098771B2 (ja) | 2000-10-16 |
Family
ID=19854349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP02505371A Expired - Lifetime JP3098771B2 (ja) | 1989-03-23 | 1990-03-22 | ペプチド、免疫原性のある組成物、それを含むワクチンまたは製剤、哺乳動物にlhrhに対する免疫性を付与する方法および豚の肉質を向上させる方法 |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0464124B1 (ja) |
JP (1) | JP3098771B2 (ja) |
AT (1) | ATE103297T1 (ja) |
CA (1) | CA2049325C (ja) |
DE (1) | DE69007616T2 (ja) |
DK (1) | DK0464124T3 (ja) |
ES (1) | ES2050435T3 (ja) |
HU (1) | HU214742B (ja) |
NL (1) | NL8900726A (ja) |
RU (1) | RU2078770C1 (ja) |
WO (1) | WO1990011298A1 (ja) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8713240D0 (en) * | 1987-06-05 | 1987-07-08 | Proteus Biotech Ltd | Hormones |
US5171835A (en) * | 1988-10-21 | 1992-12-15 | The Administrators Of The Tulane Educational Fund | LHRH antagonists |
US5324512A (en) * | 1990-12-26 | 1994-06-28 | The Population Council | [Gln']-luteinizing hormone releasing hormone conjugate of tetanus vaccine and its uses |
PT501882E (pt) * | 1991-03-01 | 2000-12-29 | Merial Sas | Processo de imunoneutralizacao anti-lhrm de animais domesticos machos nao castrados e peptido para esse fim |
US5723129A (en) * | 1991-10-16 | 1998-03-03 | University Of Saskatchewan | GnRH-leukotoxin chimeras |
US5837268A (en) * | 1991-10-16 | 1998-11-17 | University Of Saskatchewan | GnRH-leukotoxin chimeras |
ZA934199B (en) * | 1992-06-18 | 1994-01-10 | Akzo Nv | Carrier system against gnrh |
US5759551A (en) * | 1993-04-27 | 1998-06-02 | United Biomedical, Inc. | Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines |
DK0832107T3 (da) * | 1995-06-07 | 2001-11-19 | Dlo Inst Voor Dierhouderij En | Forbedret peptid, immunogen sammensætning og vaccine eller medicinsk præparat, fremgangsmåde til immunisering af dyr mod hormonet LHRH samt analoge af LHRH-tandempeptid-gentagelsespeptidet og deres andvendelse som vaccine |
US6761890B1 (en) | 1995-06-07 | 2004-07-13 | Pepscan Systems B.V. | Peptide, immunogenic composition and vaccine or medical preparation, a method to immunize animals against the hormone LHRH, and analogs of the LHRH tandem repeat peptide and their use as vaccine |
USRE39048E1 (en) | 1995-06-07 | 2006-03-28 | Pepscan Systems B.V. | Peptide, immunogenic composition and vaccine or medical preparation, a method to immunise animals against the hormone LHRH, and analogs of the LHRH tandem repeat peptide and their use as vaccine |
BR9709993A (pt) * | 1996-06-25 | 1999-08-10 | Stichting Inst Dierhouderij | Vacina preparação de vacina composição processo para produção de uma preparação imugênica e preparação imugênica |
AUPO776897A0 (en) | 1997-07-09 | 1997-07-31 | Csl Limited | A method of achieving production gains in livestock and agents useful for same |
AU771556B2 (en) * | 1998-06-04 | 2004-03-25 | Metamorphix International, Inc. | Methods for suppressing reproductive behavior in animals |
US6838553B1 (en) * | 1999-10-05 | 2005-01-04 | Academia Sinica | Peptide repeat immunogens |
NZ576739A (en) | 2003-04-22 | 2011-01-28 | Sod Conseils Rech Applic | Peptide vectors for delivering paclitaxel |
CU23739A1 (es) | 2008-09-30 | 2011-12-28 | Ct Ingenieria Genetica Biotech | Composición farmacéutica utilizando combinaciones de variantes de la hormona liberadora de las gonadotropinas (gnrh) como inmunógeno |
RU2521652C2 (ru) * | 2010-12-27 | 2014-07-10 | Общество с ограниченной ответственностью "Научно-внедренческое предприятие "Астрафарм" | РЕКОМБИНАНТНАЯ ДНК, КОДИРУЮЩАЯ ГИБРИДНЫЙ ВАКЦИННЫЙ БЕЛОК GHbc ДЛЯ РЕГУЛЯЦИИ ПОЛОВОЙ ФУНКЦИИ У ЖИВОТНЫХ, СОСТОЯЩИЙ ИЗ НУКЛЕОКАПСИДНОГО БЕЛКА ВИРУСА ГЕПАТИТА В ЧЕЛОВЕКА СЛИТОГО С ГОНАДОЛИБЕРИНОМ |
RU2529959C1 (ru) * | 2013-10-09 | 2014-10-10 | Общество с ограниченной ответственностью ООО "Нанолек" | Иммунологический адъювант на основе наночастиц для вакцин против высокопатогенных штаммов вируса гриппа |
EP3842067A1 (en) * | 2014-07-25 | 2021-06-30 | United Biomedical, Inc. | Immunogenic lhrh composition and use thereof in pigs |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4608251A (en) * | 1984-11-09 | 1986-08-26 | Pitman-Moore, Inc. | LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues |
WO1988005308A1 (en) * | 1987-01-14 | 1988-07-28 | Commonwealth Scientific And Industrial Research Or | Anti reproductive hormone |
-
1989
- 1989-03-23 NL NL8900726A patent/NL8900726A/nl not_active Application Discontinuation
-
1990
- 1990-03-22 WO PCT/NL1990/000037 patent/WO1990011298A1/en active IP Right Grant
- 1990-03-22 RU SU905001726A patent/RU2078770C1/ru active
- 1990-03-22 ES ES90905697T patent/ES2050435T3/es not_active Expired - Lifetime
- 1990-03-22 JP JP02505371A patent/JP3098771B2/ja not_active Expired - Lifetime
- 1990-03-22 EP EP90905697A patent/EP0464124B1/en not_active Expired - Lifetime
- 1990-03-22 AT AT90905697T patent/ATE103297T1/de not_active IP Right Cessation
- 1990-03-22 HU HU902930A patent/HU214742B/hu unknown
- 1990-03-22 CA CA002049325A patent/CA2049325C/en not_active Expired - Lifetime
- 1990-03-22 DK DK90905697.0T patent/DK0464124T3/da active
- 1990-03-22 DE DE69007616T patent/DE69007616T2/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP3098771B2 (ja) | 2000-10-16 |
HU214742B (hu) | 1998-10-28 |
NL8900726A (nl) | 1990-10-16 |
HUT62916A (en) | 1993-06-28 |
EP0464124A1 (en) | 1992-01-08 |
ES2050435T3 (es) | 1994-05-16 |
CA2049325A1 (en) | 1990-09-24 |
ATE103297T1 (de) | 1994-04-15 |
EP0464124B1 (en) | 1994-03-23 |
DK0464124T3 (da) | 1994-05-02 |
CA2049325C (en) | 2000-07-25 |
DE69007616D1 (de) | 1994-04-28 |
DE69007616T2 (de) | 1994-06-30 |
RU2078770C1 (ru) | 1997-05-10 |
WO1990011298A1 (en) | 1990-10-04 |
HU902930D0 (en) | 1991-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH04504256A (ja) | ペプチド、免疫原性のある組成物、それを含むワクチンまたは製剤、哺乳動物にlhrhに対する免疫性を付与する方法および豚の肉質を向上させる方法 | |
KR100257214B1 (ko) | 거세되지 않은 수컷가축의 고기의 관능적 품질을 개선하기 위한 방법 | |
JP5231378B2 (ja) | 免疫原性lhrh組成物およびそれに関する方法 | |
CA2255888A1 (en) | Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof | |
RU2147307C1 (ru) | Улучшенный пептид, иммуногенная композиция и вакцина с его использованием, способ иммунизации животных против гормона лгвг | |
US6284733B1 (en) | Peptide, immunogenic composition and vaccine or medical preparation, a method to immunize animals against the hormone LHRH, and analogs of the LHRH tandem repeat peptide and their use as vaccine | |
US5484592A (en) | Peptide, immunogenic composition and vaccine or medicinal preparation: a method of immunising a mammal against LHRH, and a method of improving the meat quality of pigs | |
US20050239701A1 (en) | Transient and/or permanent modification of sexual behavior and/or fertility using recombinant chimeric GnRH | |
JPH11515013A (ja) | 合成複合ワクチンの免疫原性担体としてのシュードモナスエクソトキシン | |
JPH03503403A (ja) | 生物学的に活性な分子 | |
JPH11514380A (ja) | GnRH/シュードモナス還元型菌体外毒素結合体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R370 | Written measure of declining of transfer procedure |
Free format text: JAPANESE INTERMEDIATE CODE: R370 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: R3D02 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080811 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080811 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090811 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090811 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100811 Year of fee payment: 10 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100811 Year of fee payment: 10 |